Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
A selection of articles from the 2016 issue of Paths of Progress.
Download this issue for your iPad from iTunes
To see the entire publication, please
download the PDF version. If you'd like to receive a print version of Paths of Progress in the
complete this form.
A promising new class of cancer drugs is emerging after nearly three decades of research.
Bringing new understanding and innovative therapies to esophageal and gastric cancers.
A closer look at aspirin and other common medicine cabinet compounds that may yet hold vital keys to preventing some cancers.
A retrospective look at the visionary leadership of outgoing Dana-Farber President and CEO Edward J. Benz Jr., MD.
Posted on April 15, 2016
For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to firstname.lastname@example.org.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.